Scientific Publications

Legend Biotech sponsors research with academic institutions to evaluate our agents. The manuscripts from this research are presented below.

Year :

Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA-specific CAR-T therapy: A retrospective analysis of LEGEND-2

Rui Liu, Rui Yang, Xuezhu Xu, Wanhong Zhao, Fangxia Wang, Wanggang Zhang, Bo Lei, Ruoyu Yang, Yiwen Wang, Aili He, Jianli Wang

Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study

Maria-Victoria Mateos, Katja Weisel, Joris Diels, Alberto Arribas, Maria Tamayo, Jordan M. Schecter, Tito Roccia, Imène Haddad, Lida Pacaud, Philippe Moreau

Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective

Doris K Hansen, Todd Bixby, Karen Fixler, Lisa Shea, Christine Brittle, Kimberly Brunisholz, Yi-Hsuan Liu, Jinhai Stephen Huo

Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma

Mary Steinbach, Laura J Zitella, Erika Florendo, Erin Lee, Carrie Riccobono, Heather DiFilippo, Elizabeth Aronson

Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study

M Htut, B Dhakal, AD Cohen, T Martin, JG Berdeja, SZ Usmani, M Agha, CC. Jackson, D Madduri, W Deraedt, E Zudaire, T Yeh, X Xu, L Pacaud, M Akram, S Jagannath


You are about to leave

You are going to a website that Legend Biotech does not operate and to which Legend Biotech's privacy policy does not apply. Legend Biotech is not responsible for the content, format, maintenance or policies of the website you are about to visit and does not endorse or monitor any content on such website.

We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.